![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
GSK plc | NYSE:GSK | NYSE | Depository Receipt |
Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.15 | -0.34% | 43.62 | 5,800 | 12:00:44 |
Resolution
|
Total votes for
*
|
%
|
Total votes against
|
%
|
Total votes cast
|
Votes withheld
**
|
|
1
|
Receive
and adopt the 2017 Annual Report
|
3,774,060,035
|
96.85
|
122,642,168
|
3.15
|
3,896,702,203
|
9,102,585
|
2
|
Approve
the Annual report on remuneration
|
2,851,170,418
|
90.41
|
302,423,307
|
9.59
|
3,153,593,725
|
752,204,847
|
3
|
Election
of Dr Hal Barron
|
3,881,663,314
|
99.53
|
18,181,557
|
0.47
|
3,899,844,871
|
5,937,889
|
4
|
Election
of Dr Laurie Glimcher
|
3,886,364,801
|
99.64
|
13,925,416
|
0.36
|
3,900,290,217
|
5,484,445
|
5
|
Re-election
of Philip Hampton
|
3,880,514,761
|
99.49
|
19,714,243
|
0.51
|
3,900,229,004
|
5,551,448
|
6
|
Re-election
of Emma Walmsley
|
3,885,288,493
|
99.61
|
15,236,656
|
0.39
|
3,900,525,149
|
5,261,280
|
7
|
Re-election
of Vindi Banga
|
3,874,981,084
|
99.37
|
24,610,295
|
0.63
|
3,899,591,379
|
6,184,729
|
8
|
Re-election
of Dr Vivienne Cox
|
3,784,417,872
|
97.05
|
114,935,231
|
2.95
|
3,899,353,103
|
6,421,540
|
9
|
Re-election
of Simon Dingemans
|
3,826,327,989
|
98.12
|
73,437,843
|
1.88
|
3,899,765,832
|
6,009,962
|
10
|
Re-election
of Lynn Elsenhans
|
3,877,253,828
|
99.41
|
23,041,318
|
0.59
|
3,900,295,146
|
5,478,806
|
11
|
Re-election
of Dr Jesse Goodman
|
3,886,003,347
|
99.63
|
14,266,676
|
0.37
|
3,900,270,023
|
5,506,284
|
12
|
Re-election
of Judy Lewent
|
3,794,070,532
|
97.29
|
105,710,801
|
2.71
|
3,899,781,333
|
5,994,672
|
13
|
Re-election
of Urs Rohner
|
3,871,948,993
|
99.29
|
27,625,403
|
0.71
|
3,899,574,396
|
6,201,911
|
14
|
Appointment
of Deloitte LLP as the auditors
|
3,892,781,525
|
99.79
|
8,074,204
|
0.21
|
3,900,855,729
|
4,930,709
|
15
|
Remuneration
of auditors
|
3,889,076,112
|
99.71
|
11,291,626
|
0.29
|
3,900,367,738
|
5,413,277
|
16
|
Authority
for the company to make donations to political organisations and
incur political expenditure
|
3,814,639,515
|
97.86
|
83,559,851
|
2.14
|
3,898,199,366
|
7,600,333
|
17
|
Authority
to allot shares
|
3,749,621,504
|
96.23
|
147,032,649
|
3.77
|
3,896,654,153
|
9,128,625
|
18
|
Disapplication
of pre-emption rights - general power
***
|
3,792,164,960
|
97.38
|
101,981,885
|
2.62
|
3,894,146,845
|
11,614,736
|
19
|
Disapplication
of pre-emption rights - in connection with an acquisition or
specified capital investment
***
|
3,675,122,062
|
94.36
|
219,534,966
|
5.64
|
3,894,657,028
|
11,110,220
|
20
|
Authority
for the company to purchase its own shares
***
|
3,834,088,739
|
98.40
|
62,147,383
|
1.60
|
3,896,236,122
|
9,555,694
|
21
|
Exemption
from statement of senior statutory auditor's name
|
3,864,323,350
|
99.16
|
32,625,496
|
0.84
|
3,896,948,846
|
8,825,695
|
22
|
Authority
for reduced notice of a general meeting other than an
AGM
***
|
3,641,775,376
|
93.45
|
255,347,155
|
6.55
|
3,897,122,531
|
8,662,254
|
23
|
Approve
the adoption of new Articles of Association
***
|
3,883,973,088
|
99.79
|
8,108,271
|
0.21
|
3,892,081,359
|
11,790,307
|
*
|
Includes
discretionary votes.
|
**
|
A vote
withheld is not a vote in law and is not counted in the calculation
of the proportion of votes "For" or "Against" a
resolution.
|
***
|
Indicates
Special Resolutions requiring a 75% majority.
|
|
GSK's
Eighteen
AGM
(2018)
|
GSK's
Seventeenth
AGM
(2017)
|
Issued
share capital (excluding Treasury Shares)
|
4,959,302,644
|
4,917,502,476
|
Total
votes cast and votes withheld lodged as a % of GSK's issued share
capital (excluding Treasury Shares)
|
78.76%
|
74.43%
|
Total
shareholder population
|
112,326
|
116,502
|
Total
number of proxies lodged
|
6,931
|
7,336
|
% of
shareholders who lodged proxies
|
6.17%
|
6.30%
|
Number
of shareholders, corporate representatives and proxies who attended
the AGM
|
415
|
435
|
|
GlaxoSmithKline plc
|
|
(Registrant)
|
|
|
Date: May
03,2018
|
|
|
|
|
By: VICTORIA
WHYTE
|
|
|
|
Victoria Whyte
|
|
Authorised
Signatory for and on
|
|
behalf
of GlaxoSmithKline plc
|
1 Year GSK Chart |
1 Month GSK Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions